Financials
- Market Capitalization 696.98 M
- Employee 942
- Founded 2007
- CEO N/A
- Website www.castlebiosciences.com
- Headquarter Delaware, United States
- FIGI BBG006YWVSR3
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2522 | OPK Opko Health, Inc. - Common Stock | 1.23 USD | -8.89% | -17.45% | -13.99% | -8.89% | 928.76 M USD | ||
| 2641 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 5.50 USD | -1.43% | +0.73% | +24.15% | +250.32% | 768.15 M USD | ||
| 2823 | FLGT Fulgent Genetics, Inc. - Common Stock | 20.42 USD | -0.63% | -4.98% | +8.39% | -13.58% | 579.94 M USD | ||
| 2855 | MYGN Myriad Genetics, Inc. - Common Stock | 5.86 USD | +0.51% | -3.78% | +35.96% | -29.14% | 553.47 M USD |
Frequently asked questions about Castle Biosciences, Inc. - Common stock
What is the Castle Biosciences, Inc. - Common stock stock price today?
The current price of Castle Biosciences, Inc. - Common stock (CSTL) is 22.98. Over the past 24 hours, the stock has changed by -3.12%. Follow the CSTL chart for real-time price dynamics.
What is the stock ticker of Castle Biosciences, Inc. - Common stock?
Castle Biosciences, Inc. - Common stock trades under the ticker CSTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Castle Biosciences, Inc. - Common stock stock going up?
CSTL has changed by -5.67% over the last week, +10.85% over the last month, and -6.64% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Castle Biosciences, Inc. - Common stock net income for the last quarter?
Castle Biosciences, Inc. - Common stock reported net income of -14.52 M for the last quarter. The previous quarter showed -2.33 M, which means net income changed by -522.73%.
How many employees does Castle Biosciences, Inc. - Common stock have?
As of the latest available data, Castle Biosciences, Inc. - Common stock has 942 employees. Workforce size can provide additional context about the company's scale and operations.
What is Castle Biosciences, Inc. - Common stock EBITDA?
Castle Biosciences, Inc. - Common stock EBITDA is -14.6 M, and its EBITDA margin is -17.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Castle Biosciences, Inc. - Common stock stock?
You can buy Castle Biosciences, Inc. - Common stock (CSTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Castle Biosciences, Inc. - Common stock stock?
Investing in Castle Biosciences, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSTL chart and related analysis on metatrader.com as part of your research.